Nurses provide a leadership role in the prevention, diagnosis, and management of emergent treatment side effects associated with novel therapeutics. The International Myeloma Foundation’s Nurse Leadership Board has developed consensus recommendations for the optimal management of these clinical challenges through a rigorous examination of scientific-based evidence and practitioner experience.
This symposium will also discuss updated clinical data and introduce key consensus recommendations that will provide nurses with a valuable clinical management tool for improving patient care.
The faculty for this symposium are members of the IMF Nurse Leadership Board. The Board’s purpose and vision is to foster a partnership with multiple myeloma nurses to identify and address their unmet needs as well as those of their patients.
To register, click the register button and use the password "ONS."
If you have any questions, please contact Bill McKenna with CMEFirst at email@example.com.